NCT02910804View on ClinicalTrials.gov

IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Glioblastoma
Interventions
DRUG

68Ga-BBN-IRDye800CW

DEVICE

PET/NIRF

PROCEDURE

PET/NIR fluorescent imaging-guided surgery

Trial Locations (1)

100050

RECRUITING

Beijing Tiantan Hospital, Capital Medical University, Beijing

Sponsors
All Listed Sponsors
collaborator

Peking Union Medical College Hospital

OTHER

collaborator

National Institute for Biomedical Imaging and Bioengineering (NIBIB)

NIH

collaborator

Chinese Academy of Sciences

OTHER_GOV

lead

Beijing Tiantan Hospital

OTHER

NCT02910804 - IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma | Biotech Hunter | Biotech Hunter